58 results
6-K
EX-4.1
QNTM
Quantum BioPharma Ltd
26 Aug 24
Current report (foreign)
6:04pm
, proceeding, litigation, investigation, judgment, damage, Loss, cost, expense or liability however arising, whether present, unascertained, immediate, future … reasonable investigation and due enquiry, or (ii) with respect to Licensee, the actual knowledge of its directors and officers, after reasonable
6-K/A
EX-99.1
QNTM
Quantum BioPharma Ltd
19 Aug 24
Condensed consolidated interim financial statements
5:18pm
Officer following the Company’s annual general and special meeting of shareholders on May 14, 2021, pending the outcome of an investigation
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
14 Aug 24
Condensed consolidated interim financial statements
6:13am
Executive Officer following the Company’s annual general and special meeting of shareholders on May 14, 2021, pending the outcome of an investigation
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
review of the independent accountants or PCAOB review or inspection of the firm, or by any other inquiry or investigation by governmental or professional
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
15 May 24
Condensed consolidated interim financial statements
6:02am
of shareholders on May 14, 2021, pending the outcome of an investigation of various concerns by a Special Committee comprised of independent directors using
6-K
swpkzkq5l3
21 Feb 24
Current report (foreign)
8:46pm
6-K
EX-10.1
o3wr0csig xats2csc
20 Feb 24
FSD Pharma Announces US ATM Offering
6:01am
424B5
gandun4
16 Feb 24
Prospectus supplement for primary offering
6:36pm
F-3
s5uw7sgkpgeb
22 Dec 23
Shelf registration (foreign)
6:49pm
F-3
EX-5.1
8cykz
22 Dec 23
Shelf registration (foreign)
6:49pm
6-K
EX-99.1
ej4t3hddzk3nguqo xu
15 Nov 23
Condensed consolidated interim financial statements
12:00am
6-K
EX-99.1
ilwvnentn si9a4plt
6 Nov 23
Current report (foreign)
6:36pm
6-K
EX-99.1
nbr5xb
20 Jul 23
Condensed consolidated interim financial statements
5:05pm
6-K
EX-99.1
z7qd 1u6xmx
10 Jul 23
FSD Pharma Inc. 6-K
7:30am
6-K
1ilq2308xjwc9v8vtt9v
10 Jul 23
FSD Pharma Inc. 6-K
7:30am
6-K
EX-99.1
axvq4i9
12 May 23
Condensed consolidated interim financial statements
6:55pm